• Perioperative Bleeding and Aspirin Use in Spine Surgery

  NCT02807441

  WithdrawnInterventionalPhase 3Updated Oct 11, 2021
• Chronic Subdural Hematoma and Aspirin

  NCT03120182

  CompletedInterventionalNot ApplicableUpdated May 13, 2024
• Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass Grafting

  NCT03049085

  Unknown statusInterventionalPhase 4Updated Feb 9, 2017
• Perioperative Aspirin Usage Survey

  NCT02561507

  TerminatedObservationalUpdated Jan 8, 2024
• Early Prophylactic Aspirin for Aneurysmal Subarachnoid Hemorrhage

  NCT07642427

  Not yet recruitingInterventionalPhase 4Updated Jun 11, 2026
• Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate

  NCT00861367

  WithdrawnInterventionalNot ApplicableUpdated Mar 19, 2024

ClinicalTrials.gov ID

NCT07086183

Lead Sponsor

Mayo ClinicOTHER

Overall Status

Not yet recruiting

Study Type

Observational

Enrollment

100Estimated

Last Update Posted

Jan 7, 2026Actual

Start Date

Dec 1, 2026Estimated

Primary Completion Date

Dec 1, 2027Estimated

Completion Date

Dec 1, 2027Estimated

Official Title

Assessing Surgical Perioperative rIsk in Patients on chRonic aspIrN Therapy Undergoing Elective Craniotomy for Aneurysm Clipping: a Prospective Multi-center Observational Study (ASPIRIN)

Brief Summary

This study is looking at how taking aspirin regularly affects bleeding during and after brain surgery. Specifically, it focuses on patients who are having elective surgery to clip a brain aneurysm.

Aspirin is commonly used to prevent heart attacks and strokes, but it can also increase the risk of bleeding. Doctors often face a tough decision: should patients stop taking aspirin before surgery to reduce bleeding risk, or continue it to prevent blood clots?

To help answer this question, researchers will observe 100 patients, some who take aspirin regularly and some who don't, at hospitals in the U.S., Russia, and Italy. They will not change any treatments but will collect information about bleeding during surgery, blood test results, and CT scans after surgery.

The goal is to better understand the risks of continuing aspirin and to help doctors make safer decisions for future patients.

• Aneurysm Cerebral

• Observation

Ages Eligible for Study

Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• Age > or = 18 years old
• Patients willing to participate and provide an informed consent
• Patients undergoing elective craniotomy for cerebral aneurysm clipping
• Patients on chronic low-dose (75-100 mg) aspirin daily (aspirin group) or not on aspirin therapy for at least 7 days (control group) preoperatively.

Exclusion Criteria:

• Emergency craniotomy
• Use of other antiplatelet or anticoagulant medications within 7 days prior to surgery
• Known bleeding disorders (e.g. hemophilia, thrombocytopenia)
• History of intracranial hemorrhage unrelated to aneurysm
• Inability to provide informed consent

Observational Model

Cohort

Time Perspective

Prospective

Lead Sponsor

Mayo ClinicOTHER

bilotta@tiscali.it+39 06 49911